Neofuse    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
70Spinal stenosis5

70. Spinal stenosis    [ 91 clinical trials,   195 drugs,   (DrugBank: 54 drugs),   60 drug target genes,   85 drug target pathways]
Searched query = "Spinal stenosis", "Extensive spinal canal stenosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
5 / 91 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01106417
(ClinicalTrials.gov)
June 201016/4/2010Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and FusionPhase 2 Study Evaluating Safety and Preliminary Efficacy of NeoFuse When Combined With MasterGraft Matrix in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and Fusion With Anterior Cervical Plate FixationCervical Degenerative Disc Disease;Degenerative Spondylolisthesis;Spinal StenosisBiological: NeoFuse;Device: MasterGraft GranulesMesoblast, Ltd.NULLCompleted18 Years70 YearsAll12Phase 1;Phase 2Australia
2NCT01097486
(ClinicalTrials.gov)
June 201030/3/2010Safety and Preliminary Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical DiscectomyPhase 2 Study Evaluating Safety and Preliminary Efficacy of NeoFuse When Combined With MasterGraft Matrix in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and Fusion With Anterior Cervical Plate FixationCervical Degenerative Disc Disease;Degenerative Spondylolisthesis;Spinal StenosisBiological: NeoFuse;Procedure: AllograftMesoblast, Ltd.NULLCompleted18 Years70 YearsAll24Phase 2United States
3NCT00996073
(ClinicalTrials.gov)
September 20099/10/2009Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody FusionA Prospective, Multicenter, Randomized, Open-Label, Controlled Study Evaluating Safety and Preliminary Efficacy of NeoFuse When Combined With MasterGraft Matrix in Subjects Undergoing Lumbar Interbody Fusion With InstrumentationDegenerative Disc Disease;Degenerative Spondylolisthesis;Spinal StenosisBiological: Lumbar Interbody Fusion with Autograft;Biological: Lumbar Interbody Fusion with NeoFuseMesoblast, Ltd.NULLCompleted18 Years70 YearsAll24Phase 2United States
4NCT00810212
(ClinicalTrials.gov)
November 200817/12/2008Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar FusionA Prospective, Multicenter, Randomized, Open-Label, Controlled Study Evaluating Safety and Preliminary Efficacy of NeoFuse When Combined With Mastergraft Granules in Subjects Undergoing Posterolateral Lumbar Fusion With InstrumentationDegenerative Disc Disease;Degenerative Spondylolisthesis;Spinal StenosisProcedure: PLF with autograft;Biological: PLF with NeoFuseMesoblast, Ltd.NULLWithdrawn18 Years70 YearsAll0Phase 1;Phase 2United States
5NCT00549913
(ClinicalTrials.gov)
October 200724/10/2007Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF)A Dose-escalation Study to Assess the Feasibility and Safety of 3 Different Doses of NeoFuse When Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion With Instrumentation.Degenerative Disc Disease;Spondylolisthesis;Spinal StenosisBiological: NeoFuse;Procedure: posterolateral spinal fusion with instrumentationMesoblast, Ltd.NULLCompleted18 YearsN/AAll6Phase 1;Phase 2United States